Walt Harris temporarily suspended by CSAC after positive UFC 232 drug test

UFC heavyweight Walt Harris failed a fight-night drug test at UFC 232 and is now temporarily suspended by the California State Athletic Commission (CSAC).

Harris (12-7 MMA, 5-6 UFC), who defeated ex-champ Andrei Arlovski (27-18 MMA, 16-12 UFC) in a lackluster split decision at the Dec. 28 pay-per-view event at The Forum in Inglewood, Calif., was tested by the CSAC and came back positive for LGD4033, a muscle-wasting medication in the same family of selective androgen receptor modulators (SARMs) like ostarine, which has been at the center of several anti-doping cases involving tainted supplements.

Although the U.S. Anti-Doping Agency (USADA) administers the UFC’s anti-doping program, the CSAC also conducts drug tests on selected athletes, as do many state athletic commissions where UFC events are held.

CSAC Executive Director Andy Foster said Harris’ team has already offered a supplement Harris took and added the supplement – along with the fighter’s “B” sample – will be tested to determine if it was tainted with the banned substance. The case will be dealt with administratively unless Harris contests the commission’s findings, Foster added.

As a UFC athlete, Harris, 35, also faces disciplinary action from USADA. UFC VP of Athlete Health and Performance Jeff Novitzky told MMAFighting.com – which first broke news of Harris’ positive test – that he’s been informed of the result and will leave the matter to the CSAC. Novitzky added that Harris’ most recent test conducted by USADA was Nov. 30, 2018, and came back negative.

Novitzky did not respond to a request for comment to MMAjunkie.

Harris’ win over Arlovski at UFC 232 currently stands. He also faces an undetermined fine for the failed test.

For complete coverage of UFC 232, check out the UFC Events section of the site.

Source: USA Today – MMA Junkie

Read the full article here: Walt Harris temporarily suspended by CSAC after positive UFC 232 drug test